These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34273481)

  • 1. MATERNAL AND FETAL BUPRENORPHINE PHARMACOKINETICS IN PREGNANT SHEEP DURING TRANSDERMAL PATCH DOSING: Buprenorphine pharmacokinetics in pregnant sheep.
    Hakomäki H; Kokki H; Lehtonen M; Räsänen J; Voipio HM; Ranta VP; Kokki M
    Eur J Pharm Sci; 2021 Oct; 165():105936. PubMed ID: 34273481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system distribution of buprenorphine in pregnant sheep, fetuses and newborn lambs after continuous transdermal and single subcutaneous extended-release dosing.
    Hakomäki H; Eskola S; Kokki H; Lehtonen M; Räsänen J; Laaksonen S; Voipio HM; Ranta VP; Kokki M
    Eur J Pharm Sci; 2022 Nov; 178():106283. PubMed ID: 36029997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of buprenorphine in pregnant sheep after intravenous injection.
    Hakomäki H; Kokki H; Lehtonen M; Ranta VP; Räsänen J; Voipio HM; Kokki M
    Pharmacol Res Perspect; 2021 Apr; 9(2):e00726. PubMed ID: 33619904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foetal Fentanyl Exposure and Ion Trapping after Intravenous and Transdermal Administration to the Ewe.
    Heikkinen EM; Kokki H; Heikkinen A; Ranta VP; Räsänen J; Voipio HM; Kokki M
    Basic Clin Pharmacol Toxicol; 2017 Feb; 120(2):195-198. PubMed ID: 27607410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of analgesic efficacy and fetal effects between transdermal administration of fentanyl and intramuscular administration of buprenorphine in pregnant sheep.
    Padgett AL; Lepiz ML; Mackay EE; Driskill AJ; Ivanov IV; Fajt VR; Konarik MM; Mays TP; Washburn SE
    Am J Vet Res; 2020 Jul; 81(7):581-593. PubMed ID: 32584185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (R)- and (S)-methadone and buprenorphine concentration ratios in maternal and umbilical cord plasma following chronic maintenance dosing in pregnancy.
    Gordon AL; Lopatko OV; Somogyi AA; Foster DJ; White JM
    Br J Clin Pharmacol; 2010 Dec; 70(6):895-902. PubMed ID: 21175445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxycodone pharmacokinetics and fetal exposure after intravenous or epidural administration to the ewe.
    Kinnunen M; Kokki H; Hautajärvi H; Huhta H; Ranta VP; Räsänen J; Voipio HM; Kokki M
    Acta Obstet Gynecol Scand; 2018 Oct; 97(10):1200-1205. PubMed ID: 29772054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-adjusted plasma concentrations of sublingual buprenorphine are lower during than after pregnancy.
    Bastian JR; Chen H; Zhang H; Rothenberger S; Tarter R; English D; Venkataramanan R; Caritis SN
    Am J Obstet Gynecol; 2017 Jan; 216(1):64.e1-64.e7. PubMed ID: 27687214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine plasma and cerebrospinal fluid concentrations in osteoarthritis patients during low-dose transdermal patch dosing.
    Härkänen L; Hakomäki H; Huopio J; Kokki H; Korhonen S; Lehtonen M; Sjövall S; Kokki M
    Eur J Clin Pharmacol; 2023 Dec; 79(12):1709-1711. PubMed ID: 37864723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of transdermal buprenorphine patch in the elderly.
    Al-Tawil N; Odar-Cederlöf I; Berggren AC; Johnson HE; Persson J
    Eur J Clin Pharmacol; 2013 Feb; 69(2):143-9. PubMed ID: 22706617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buprenorphine exposure in infants of opioid-dependent mothers at birth.
    Bartu AE; Ilett KF; Hackett LP; Doherty DA; Hamilton D
    Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):342-7. PubMed ID: 22428721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Accumulation of Methadone Compared with Buprenorphine in Fetal Rat Brain after Maternal Exposure.
    Kongstorp M; Bogen IL; Stiris T; Andersen JM
    J Pharmacol Exp Ther; 2019 Oct; 371(1):130-137. PubMed ID: 31358559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diurnal rhythms in plasma melatonin concentrations in the fetal sheep and pregnant ewe during late gestation.
    Zemdegs IZ; McMillen IC; Walker DW; Thorburn GD; Nowak R
    Endocrinology; 1988 Jul; 123(1):284-9. PubMed ID: 3383776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome.
    Griffin BA; Caperton CO; Russell LN; Cabanlong CV; Wilson CD; Urquhart KR; Martins BS; Zita MD; Patton AL; Alund AW; Owens SM; Fantegrossi WE; Moran JH; Brents LK
    J Pharmacol Exp Ther; 2019 Jul; 370(1):9-17. PubMed ID: 31028107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated dose exposure of the neonate to buprenorphine and its metabolite norbuprenorphine via breastmilk during maternal buprenorphine substitution treatment.
    Ilett KF; Hackett LP; Gower S; Doherty DA; Hamilton D; Bartu AE
    Breastfeed Med; 2012 Aug; 7():269-74. PubMed ID: 22011128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The uptake of transdermal fentanyl in a pregnant sheep model.
    Musk GC; Catanchin CSM; Usuda H; Woodward E; Kemp MW
    Vet Anaesth Analg; 2017 Nov; 44(6):1382-1390. PubMed ID: 29174960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of saquinavir, methadone, and buprenorphine in maternal brain, placenta, and fetus during two different gestational stages of pregnancy in mice.
    Coles LD; Lee IJ; Hassan HE; Eddington ND
    J Pharm Sci; 2009 Aug; 98(8):2832-46. PubMed ID: 19116954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal buprenorphine treatment and fetal neurobehavioral development.
    Jansson LM; Velez M; McConnell K; Spencer N; Tuten M; Jones HE; King VL; Gandotra N; Milio LA; Voegtline K; DiPietro JA
    Am J Obstet Gynecol; 2017 May; 216(5):529.e1-529.e8. PubMed ID: 28188773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma buprenorphine concentrations after the application of a 70 microg/h transdermal patch in dogs. Preliminary report.
    Andaluz A; Moll X; Ventura R; Abellán R; Fresno L; García F
    J Vet Pharmacol Ther; 2009 Oct; 32(5):503-5. PubMed ID: 19754919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evidence-based recommendation to increase the dosing frequency of buprenorphine during pregnancy.
    Caritis SN; Bastian JR; Zhang H; Kalluri H; English D; England M; Bobby S; Venkataramanan R
    Am J Obstet Gynecol; 2017 Oct; 217(4):459.e1-459.e6. PubMed ID: 28669739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.